The Streptococcus pyogenes CRISPR/Cas system has found widespread applications as a gene-editing and regulatory tool for the simultaneous delivery of the Cas9 protein and guide RNAs into the cell, thus making the recognition of specific DNA sequences possible. The recent study that shows that Cas9 can also bind to and cleave RNA in an RNA-programmable manner is suggestive of potential utility of this system as a universal nucleic-acid recognition tool. To increase the signal intensity of the CRISPR/Cas system, a signal amplification technique has to be exploited appropriately; this requirement is also a challenge for the detection of DNA or RNA.
in the sgRNA are customizable, 2 which makes the design of sgRNA easy in practice, greatly expanding its applications in biological research. In this review, we provide a brief summary of the applications of the CRISPR/Cas system to molecular detection including detection of specific sequences of DNA or RNA, single nucleotide variants and pathogens.
| APPLICATIONS TO DETECTING SPECIFIC SEQUENCES OF DNA OR RNA
DNA fluorescence in situ hybridization (FISH) has been widely used to visualize sequence-specific genes for research and diagnostic purposes. Nonetheless, it requires heat treatments and formamide to denature double-stranded DNA (dsDNA) to enable probe hybridization; these treatments may affect integrity of the biological structure and organization of the genome. Accordingly, Baohui Chen that contain hundreds to thousands of repeats and some repetitive sequences with tens to hundreds of copies for sgRNA targeting were imaged successfully in fixed cells. Nevertheless, as to the non-repetitive sequences, the labelling efficacy of the target gene was low and the background signal was quite strong, suggesting that sgRNA's targeting efficacy should be optimized for a non-repetitive sequence.
This is because the fluorescent signal of a few dCas9-sgRNA complexes in the target region was insufficient for detection. According to the research of Baohui Chen, 7 at least 26 unique sgRNAs are needed to target the same region to obtain a detectable signal. On the other hand, this approach has been difficult to practice in biological applications because of the challenges in the delivery of dozens of sgRNAs into the cell and large numbers of off-target sites associated with the great many sgRNAs. Thus, Peiwu Qin 9 devised a robust fluorescent-signal amplification system by utilizing a re-engineered sgRNA, which contains up to 16 MS2 motifs that can bind to bacteriophage MS2 coat protein (MCP), so that they can label the target via a fluorescent tag of MCP ( Figure 1A ). The researchers improved the traditional method of targeting non-repetitive regions by employing four unique sgRNAs rather than 26 to 36 sgRNAs because the amplification effects of the large number of fluorescently tagged MCP molecules can reduce the number of dCas9/ sgRNA complexes required for reliable detection. They also determined that a further reduction in the number of sgRNAs may be possible, whereas the potential loss of dCas9 targeting specificity owing to the modification of sgRNA should be taken into account.
Apart from the signal amplification and single-colour labelling technique, multicolour CRISPR labelling of chromosomal loci has been developed: Hanhui Ma et al 10 used three orthogonal CRISPR/dCas9
components tagged with different fluorescent proteins to detect multiple loci in the genome so that this method can differentiate various chromosomal loci simultaneously and confirm the distance between the loci at the same time ( Figure 1A ). 
| APPLICATIONS TO THE DETECTION OF MUTATIONS AND SINGLE-NUCLEOTID E VARIANTS (SNVs)
It is well known that CRISPR/Cas9 has high efficacy of site-specific Moreover, they can also detect point mutations in the BRAF and NRAS genes using RGENs that recognize the "NAG" PAM sequence.
It is not easy to control the recognition and cleavage of the RNA-guided Cas9 nuclease because its specificity is dependent on the length of the sgRNA 26 and on the sequence, number, position and distribution of mismatches. 27 Courtney 28 published a new procedure for targeting a point mutation or SNP because the Cas9 protein has quite a specific DNA-binding constraint, namely, the target sequence in genomic DNA must be followed by the correct PAM sequence: 5′-NGG-3′. In addition, they found a mutation within KRT12 that causes Meesmann's epithelial corneal dystrophy and can lead to the occurrence of a novel PAM. This meant that they could design a sgRNA complementary to the sequence adjacent to this mutation-derived PAM to target and cleave the there is a spot of MSSA strains that contains the mecA gene 35, 36 ; this state of affairs make the detection of the mecA gene not specific to MRSA.
| DETECTION OF PATH OGENS

Emerging infectious diseases, such as Zika virus (ZIKV) infections in
After the Doudna 37 lab demonstrated the functions of Cas13a (formerly C2c2), which is responsible for the processing and maturation of crRNA and can degrade non-targeted RNA after cleavage of targeted RNA directed by RNA. In addition, they found in their research that distinct active sites within the Cas13a protein catalyse pre-crRNA processing and RNA-directed RNA cleavage. In addition, they determined that the two distinct catalytic activities of Cas13a can be harnessed together for RNA detection, for which the activated Cas13a is able to cleave thousands of non-targeted RNAs after cleavage of the target RNA enables potent signal amplification.
Feng Zhang also published some papers about the detection ways of nucleic acid called SHERLOCK with attomolar sensitivity and singlenucleotide mismatch specificity by means of Cas13a in tandem with recombinase polymerase amplification (RPA), which can be coupled with T7 transcription to convert amplified DNA to RNA for subsequent detection. [38] [39] [40] The sensitivity of the method combined with RPA is higher than that of any other isothermal amplification method. Cas13a is an RNA-guided RNase that can cleave the regions complementary with the crRNA thereby providing a platform for specific RNA recognition and cleavage. In addition, after cleaving the target RNA, Cas13a cannot stop cleaving nearby off-target RNAs. To take advantage of this function, the authors added some reporter RNA which is non-targeted and will release the signal when it is cut by the Cas13a-mediated collateral RNA cleavage in the reaction.
They uncover that the cleavage products of Cas13a can be activators of Csm6 which is CRISPR type-III effector nuclease. 41, 42 The Cas system with some other technique to achieve a detection goal.
The main features of the three methods are summarized in Table 1 .
As for the time and cost, the two methods that involve the CRISPR/ Cas9 system take~3 hours, whereas the dCas9/sgRNA complex combined with FISH is more inexpensive. Regarding sensitivity, 10 colony-forming units (cfu)/mL is required for detecting MRSA, which T A B L E 1 Brief summary of applications in detecting pathogens of three main methods 44 which also complicates the design of sgRNA. Secondly, the "off target" effects which may cause false negative or positive results need to be considered. The frequency of off-target sgRNA binding varies a lot, ranging from very few off-targets to great amounts. 25, 27, 45, 46 However, target sequences can be selected by online software to help reduce the probability of off-target binding, 47 and more specific variants of Cas9 protein 48, 49 or CRISPR systems from other types 50,51 may be helpful to address this issue.
Main detection system
Accompanied by the aforementioned off-targets ameliorated in the future, the accuracy of CRISPR/Cas technology in molecular detection will also be improved. Thirdly, RNA is very fragile due to ubiquitous RNase, the detection of the interested nucleic acid and mutations were prone to be affected. Therefore, it is important to make sure that the designed longer sgRNA for signal amplification of nucleic-acid detection in CRISPR/Cas9 system is not cut short or degraded by the RNase, which may cause the final result false negative. As for CRISPR/Cas13a detection system, SHERLOCK platform is in good graces for its extremely high sensitivity. Nevertheless, SHERLOCK is an exponential pre-amplification that saturates quickly after the reaction starts, which makes accurate quantification in real time quite difficult. 39 More explorations need to be done to observe a proper way about quantification of the detection and to require a wider linearity range. Collectively, further studies to solve these limitations of CRISPR/Cas technology will pave the way for the molecular detection in human diseases in vitro, including different types of cancer.
| CONCLUSION S
Since the discovery of the CRISPR/Cas system, it has been widely used for genomic editing to treat some mutation-induced diseases.
Nevertheless, there is still too much controversy regarding the applications of CRISPR/Cas9 in medical treatments due to the risk of 
